BD senior director Andrea Liebmann Vinson joins Global Health Technologies Coalition panel

Home    BD    Insight

BDs Andrea Liebmann-Vinson discusses the ROI on R&D

BD's Andrea Liebmann-Vinson discusses the ROI on R&D

Andrea Liebmann-Vinson, a senior director of BD, joined a high level panel discussion as part of the launch of a new state-by-state analysis from the Global Health Technologies Coalition (GHTC).

Andrea examined how global health research and development delivers economic and health security benefits across the United States.


GHTC is the premier advocacy organization focusing on global health R&D for new tools and technologies. GHTC is a coalition of more than 25 nonprofit organizations, academic institutions, and aligned businesses advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Funded by the Bill & Melinda Gates Foundation and our members and housed at PATH, the coalition does not advocate for specific diseases or health areas. Rather, GHTC supports policies to advance the goals of global health R&D across many disease and health areas.

BD medical GHTC


Find out more

Disclosure: Where Women Work researches and publishes insightful evidence about how its paid member organizations support women's equality.

Share this page:

Join our women's careers community